文献速递免疫规划传染病防控与疫情报告

美军人员黄热病疫苗接种后血清阳性持续时间研究

Duration of seropositivity following yellow fever vaccination in U.S. military service members.
PubMed 文献 · Vaccine · 2020-11-22

本研究评估美军人员单剂黄热病疫苗接种后5-39年的血清中和抗体阳性率,采用50% cutoff蚀斑减少中和试验检测682人。结果显示接种后10-14年阳性率95.8%(95%CI 91.2-98.1%),非劣于5-9年的97.8%(95%CI 93.7-99.3%);接种后≥20年阳性率仍>90%。结论提示多数美军人员每10年加强接种并非必需。

要点

  • 单剂黄热病疫苗后10-14年血清阳性率非劣于5-9年。
  • 接种后至少19年中和抗体阳性率>95%。
  • 接种后≥20年血清阳性率下降但仍>90%。

核心结论

  • 接种后至少19年>95%受种者存在中和抗体,提示多数美军人员每10年加强接种并非必需。

研究设计与样本

  • 对682名美军人员在接种后5-39年采用50% cutoff蚀斑减少中和试验检测血清抗体。
  • 以接种后10-14年与5-9年血清阳性率比较非劣效性,非劣效界值为双侧95%CI下限≥-0.10。
  • 比较不同时间点几何平均抗体滴度(GMT)与接种后5-9年GMT。

主要发现

  • 接种后10-14年血清阳性率95.8%(95%CI 91.2-98.1%),非劣于5-9年的97.8%(95%CI 93.7-99.3%)。
  • 接种后10-14年GMT为99(95%CI 82-121),非劣于5-9年的115(95%CI 96-139)。
  • 接种后15-19年血清阳性率98.5%(95%CI 95.5-99.7%),仍保持非劣。
  • 接种后≥20年血清阳性率下降,但仍>90%。

临床怎么用

  • 对多数美军人员,单剂黄热病疫苗后无需每10年常规加强接种。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The United States military regularly deploys thousands of service members throughout areas of South America and Africa that are endemic for yellow fever (YF) virus. To determine if booster doses might be needed for service members who are repetitively or continually deployed to YF endemic areas, we evaluated seropositivity among US military personnel receiving a single dose of YF vaccine based on time post-vaccination. METHODS: Serum antibodies were measured using a plaque reduction neutralization test with 50% cutoff in 682 military personnel at 5-39 years post-vaccination. We determined noninferiority of immune response by comparing the proportion seropositive among those vaccinated 10-14 years previously with those vaccinated 5-9 years previously. Noninferiority was supported if the lower-bound of the 2-tailed 95% CI for p10-14years - p5-9years was ≥-0.10. Additionally, the geometric mean antibody titer (GMT) at various timepoints following vaccination were compared to the GMT at 5-9 years. RESULTS: The proportion of military service members with detectable neutralizing antibodies 10-14 years after a single dose of YF vaccine (95.8%, 95% CI 91.2-98.1%) was non-inferior to the proportion 5-9 years after vaccination (97.8%, 95% CI 93.7-99.3%). Additionally, GMT among vaccine recipients at 10-14 years post vaccination (99, 95% CI 82-121) was non-inferior to GMT in YF vaccine recipients at 5-9 years post vaccination (115, 95% CI 96-139). The proportion of vaccinees with neutralizing antibodies remained high, and non-inferior, among those vaccinated 15-19 years prior (98.5%, 95%CI 95.5-99.7%). Although the proportion seropositive decreased among vaccinees ≥ 20 years post vaccination, >90% remained seropositive. CONCLUSIONS: Neutralizing antibodies were present in > 95% of vaccine recipients for at least 19 years after vaccination, suggesting that booster doses every 10 years are not essential for most U.S. military personnel.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lindsey NP, Perry L, Fischer M, et al. Duration of seropositivity following yellow fever vaccination in U.S. military service members. Vaccine. 2020. PMID: 33239225. doi:10.1016/j.vaccine.2020.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。